FDA lifts partial hold on Icagen drug;
> The FDA has lifted a partial clinical hold on Icagen's photosensitive epilepsy drug ICA-105665.
WebMD extended its poison pill defense, first put into place to ward off billionaire investor Carl Icahn, for another two years.